Abstract
Adenocarcinoma of the endometrium is the most common malignancy of the female genital tract in the United States. Many physicians believe that adenocarcinoma of the endometrium is a relatively benign disease because of the early symptoms of irregular vaginal bleeding in this predominantly postmenopausal patient population, the often-localized nature of the disease, and the generally high survival rate. However, the estimated number of deaths from endometrial cancer continues to increase, indicating the need for a critical reassessment of the guidelines for managing endometrial cancer. Physicians must identify high-risk patients and tailor treatment appropriately to provide the best opportunity for long-term survival.
Original language | English (US) |
---|---|
Pages (from-to) | 438-462 |
Number of pages | 25 |
Journal | JNCCN Journal of the National Comprehensive Cancer Network |
Volume | 4 |
Issue number | 5 |
DOIs | |
State | Published - May 2006 |
Keywords
- Chemotherapy
- Endometrial carcinoma
- Hysterectomy
- NCCN Clinical Practice Guidelines
- Radiation therapy
- Staging
- Surgery
- Uterine cancer
- Uterine sarcomas
ASJC Scopus subject areas
- Oncology